Iran on Sunday unveiled its second homegrown COVID-19 vaccine, based on a recombinant protein that can be injected or inhaled. The COV-Pars vaccine, developed by the country's oldest scientific research centre, Razi Vaccine and Serum Research Institute, is expected to undergo human trials from Monday.